Dr. James William Suliburk, MD

Dr. Suliburk practices at Baylor St. Luke's Medical Center in Houston, Texas, part of CommonSpirit Health.

Dr. Suliburk's NPI, 1811968886, was assigned on January 30, 2006. Dr. Suliburk graduated from OU College of Medicine in 2001. Dr. Suliburk's Texas license number on file is L7895.

Dr. Suliburk's primary practice is Baylor St. Luke's Medical Center, at 6720 Bertner Ave, STE Mc1-266, Houston, TX 77030 in Harris County. The practice phone is (832) 355-1000.

Dr. Suliburk's primary practice is Baylor St. Luke's Medical Center in Houston, Texas, part of CommonSpirit Health. The medical group on file is Baylor Medicine. Dmand AI also links Dr. Suliburk to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Suliburk practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Suliburk's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Suliburk is board certified in surgery by the American Board of Surgery. Dr. Suliburk has a license on file in Texas.

Dmand AI lists amputation, gallbladder removal and thyroid surgery among the conditions Dr. Suliburk treats.

CMS data shows 184 Medicare services from Dr. Suliburk across 6 procedure codes in 2024, for 65 Medicare patients. Medicare paid $28,141 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Suliburk in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Suliburk's median patient age at 64, with 77% women.

In 2024, Dr. Suliburk wrote 39 Medicare Part D claims for 15 patients. 59% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $14,080 in total drug cost. In 2020, CMS named 20 claims across 1 drug.

Dr. Suliburk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Suliburk as offering telehealth.

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 116 papers to Dr. Suliburk, published from 2005 to 2024. 2017 was the busiest year, with 8. The most frequent topics are Lipopolysaccharides, Rats, Sprague-Dawley and Nitric Oxide Synthase Type II. Dr. Suliburk has published most often in J Surg Res. Dr. Suliburk's most frequent co-authors are Lillian S. Kao, MD, Wendong Yu, MD and Kenneth S. Helmer, MD.

CMS Open Payments shows 255 general payments to Dr. Suliburk from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Corcept Therapeutics paid the most, $86,247.

Dmand AI lists 13 awards for Dr. Suliburk, most recently Fulbright and Jaworski L.L.P. Faculty Excellence Award for Teaching and Evaluation in 2016.

Dr. Suliburk graduated from OU College of Medicine in 2001. Dr. Suliburk is a member of AAES - American Association of Endocrine Surgeons, ACS and ATA.

Dr. Suliburk is in network with 20 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.